229 related articles for article (PubMed ID: 34933733)
1. Evaluation of blaGES-5 and bla veb-1 genes with multidrug-resistant extend, pandrug resistance patterns (MDR, XDR, PDR), and biofilm formation in Pseudomonas aeruginosa isolates.
Ali FA; Bakir SH; Haji SH; Hussen BM
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):52-60. PubMed ID: 34933733
[TBL] [Abstract][Full Text] [Related]
2. Association Between Biofilm Formation Gene Bla exoU and Metallo and Extend Spectrum Beta-lactamase Production of Multidrug Resistance Pseudomonas aeruginosa in Clinical Samples.
Ali FA
Comb Chem High Throughput Screen; 2022; 25(7):1207-1218. PubMed ID: 33874869
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.
Tchakal-Mesbahi A; Metref M; Singh VK; Almpani M; Rahme LG
Burns; 2021 Dec; 47(8):1833-1843. PubMed ID: 33795157
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance pattern, genetic distribution of ESBL genes, biofilm-forming potential, and virulence potential of
Shahbazzadeh M; Moazamian E; Rafati A; Fardin M
Pan Afr Med J; 2020; 36():233. PubMed ID: 33708324
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
Tawfik AF; Shibl AM; Aljohi MA; Altammami MA; Al-Agamy MH
Burns; 2012 Sep; 38(6):855-60. PubMed ID: 22348803
[TBL] [Abstract][Full Text] [Related]
7. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients.
Mirsalehian A; Feizabadi M; Nakhjavani FA; Jabalameli F; Goli H; Kalantari N
Burns; 2010 Feb; 36(1):70-4. PubMed ID: 19524369
[TBL] [Abstract][Full Text] [Related]
8. Spread of extended-spectrum β-lactamase genes of blaOXA-10, blaPER-1 and blaCTX-M in Pseudomonas aeruginosa strains isolated from burn patients.
Farshadzadeh Z; Khosravi AD; Alavi SM; Parhizgari N; Hoveizavi H
Burns; 2014 Dec; 40(8):1575-80. PubMed ID: 24767142
[TBL] [Abstract][Full Text] [Related]
9. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N
Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003
[TBL] [Abstract][Full Text] [Related]
10. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
[TBL] [Abstract][Full Text] [Related]
11. Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.
Polotto M; Casella T; de Lucca Oliveira MG; Rúbio FG; Nogueira ML; de Almeida MT; Nogueira MC
BMC Infect Dis; 2012 Aug; 12():176. PubMed ID: 22863113
[TBL] [Abstract][Full Text] [Related]
12. PME and Other ESBL-Positive Multiresistant Pseudomonas aeruginosa Isolated from Hospitalized Patients in the Region of Kurdistan, Iraq.
van Burgh S; Maghdid DM; Ganjo AR; Mansoor IY; Kok DJ; Fatah MH; Alnakshabandi AA; Asad D; Hammerum AM; Ng K; Klaassen C; Goessens WHF
Microb Drug Resist; 2019; 25(1):32-38. PubMed ID: 30067166
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran.
Shahcheraghi F; Nikbin VS; Feizabadi MM
Microb Drug Resist; 2009 Mar; 15(1):37-9. PubMed ID: 19265477
[TBL] [Abstract][Full Text] [Related]
14. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
[TBL] [Abstract][Full Text] [Related]
15. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
De Rosa A; Mutters NT; Mastroianni CM; Kaiser SJ; Günther F
Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran.
Asadpour L
J Glob Antimicrob Resist; 2018 Jun; 13():214-220. PubMed ID: 29421318
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the bla OXA , bla VEB-1 , and bla GES-1 genes and resistance patterns of ESBL-producing Pseudomonas aeruginosa isolated from hospitals in Tehran and Qazvin, Iran.
Amirkamali S; Naserpour-Farivar T; Azarhoosh K; Peymani A
Rev Soc Bras Med Trop; 2017; 50(3):315-320. PubMed ID: 28700048
[TBL] [Abstract][Full Text] [Related]
18. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
[TBL] [Abstract][Full Text] [Related]
19. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
